Overexpression of bradykinin type 2 receptors on glioma cells enhances bradykinin-mediated blood-brain tumor barrier permeability increase

Neurological Research

Volumn 24, Issue 8, 2002, Pages 739-746

  Uchida, Mikito ^a   Chen, Zutang ^a   Liu, Yunhui ^a   Black, Keith L ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

B2 receptor; Blood brain barrier; Blood brain tumor barrier; Bradykinin; Permeability

Indexed keywords

2 AMINO 2 METHYLPROPIONIC ACID; BRADYKININ; BRADYKININ B2 RECEPTOR; COMPLEMENTARY DNA;

ANIMAL CELL; ARTICLE; AUTORADIOGRAPHY; BINDING ASSAY; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DNA SEQUENCE; GLIOMA CELL; NONHUMAN; PROTEIN DETERMINATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOOD-BRAIN BARRIER; BRADYKININ; BRAIN NEOPLASMS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; RATS; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0036898706     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164102101200753     Document Type: Article

References (34)

1. Neuwelt EA, Frenkel EP, Diehl JT, Maravilla KR, Vu LH, Clark WK, Rapoport SI, Barnett PA, Hill SA, Lewis SE, Ehle AL, Beyer CW Jr, Moore RJ. Osmotic blood-brain barrier disruption: A new means of increasing chemotherapeutic agent delivery. Trans Am Neurol Assoc 1979; 104: 256-260
2. Inamura T, Black KL. Bradykinin selectively opens blood-tumor barrier in experimental brain tumors. J Cereb Blood Flow Metab 1994; 14: 862-870
3. Black KL, King WA, Ikezaki K. Selective opening of the bloodtumour barrier by intracarotid infusion of leukotriene C4. Acta Neurochir Suppl (Wien) 1990; 51: 140-141
4. Nomura T, Inamura T, Black KL. Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors. Brain Res 1994; 659: 62-66
5. Yang W, Barth RF, Bartus RT, Rotaru JH, Moeschberger ML, Ferketich AK, Nawrocky MM, Coderre JA, Goodman JH. Improved survival after boron neutron capture therapy of brain tumors by Cereport-mediated blood-brain barrier modulation to enhance delivery of boronophenylalanine [In Process Citation]. Neurosurgery 2000; 47: 189-198
6. Matsukado K, Inamura T, Nakano S, Fukui M, Bartus RT, Black KL. Enhanced tumor uptake of carboplatin and survival in gliomabearing rats by intracarotid infusion of bradykinin analog, RMP-7. Neurosurgery 1996; 39: 125-134
7. Black KL, Cloughesy T, Huang SC, Gobin YP, Zhou Y, Grous J, Nelson G, Farahani K, Hoh CK, Phelps M. Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas. J Neurosurg 1997; 86: 603-609
8. Gregor A, Lind M, Newman H, Grant R, Hadley DM, Barton T, Osborn C. Phase II studies of RMP-7 and carboplatin in the treatment of recurrent high grade glioma. RMP-7 European Study Group. J Neurooncol 1999; 44: 137-145
9. Yuan F, Salehi HA, Boucher Y, Vasthare US, Tuma RF, Jain RK. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res 1994; 54: 4564-4568
10. Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980; 32: 1-46
11. Wang DZ, Chao L, Chao J. Hypotension in transgenic mice overexpressing human bradykinin B2 receptor. Hypertension 1997; 29: 488-493
12. Mackic JB, Stins M, Jovanovic S, Kim KS, Bartus RT, B Zlokovic V. Cereport (RMP-7) increases the permeability of human brain microvascular endothelial cell monolayers. Pharm Res 1999; 16: 1360-1365
13. Matsukado K, Sugita M, Black KL. Intracarotid low dose bradykinin infusion selectively increases tumor permeability through activation of bradykinin B2 receptors in malignant gliomas. Brain Res 1998; 792: 10-15
14. Liu Y, Hashizume K, Chen Z, Samoto K, Ningaraj N, Asotra K, Black KL. Correlation between bradykinin-induced blood-tumor barrier permeability and B2 receptor expression in experimental brain tumors. Neurol Res 2001; 23: 379-387.
15. Sugita M, Black KL. Cyclic GMP-specific phosphodiesterase inhibition and intracarotid bradykinin infusion enhances permeability into brain tumors. Cancer Res 1998; 58: 914-920
16. Ohno K, Pettigrew KD, Rapoport SI. Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am J Physiol 1978; 235: H299-H307
17. Leeb-Lundberg LM, Mathis SA, Herzig 'MC. Antagonists of bradykinin that stabilize a G-protein-uncoupled state of the B2 receptor act as inverse agonists in rat myometrial cells. J Biol Chem 1994; 269: 25970-25973
18. Gelperin D, Mann D, del Valle J, Wiley JW. Bradykinin (Bk) increases cytosolic calcium in cultured rat myenteric neurons via Bk-2 type receptors coupled to mobilization of extracellular and intracellular sources of calcium: Evidence that calcium influx is prostaglandin dependent. J Pharmacol Exp Ther 1994; 271: 507-514
19. Doctrow SR, Abelleira SM, Curry LA, Heller-Harrison R, Kozarich JW, Malfroy B, McCarroll LA, Morgan KG, Morrow AR, Musso GF, et al. The bradykinin analog RMP-7 increases intracellular free calcium levels in rat brain microvascular endothelial cells. J Pharmacol Exp Ther 1994; 271: 229-237
20. Mittal CK, Mehta CS. Regulation of nitric oxide synthase: role of oxygen radicals and cations in nitric oxide formation. Adv Pharmacol 1995; 34: 235-250
21. Leybaert L, Paemeleire K, Strahonja A, Sanderson MJ. Inositoltrisphosphate-dependent intercellular calcium signaling in and between astrocytes and endothelial cells. Glia 1998; 24: 398-407
22. Braet K, Paemeleire K, D'Herde K, Sanderson MJ, Leybaert L. Astrocyte-endothelial cell calcium signals conveyed by two signalling pathways. Eur J Neurosci 2001; 13: 79-91
23. Nakano S, Matsukado K, Black KL. Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. Cancer Res 1996; 56: 4027-4031
24. Bakshi A, Nag TC, Wadhwa S, Mahapatra AK, Sarkar C. The expression of nitric oxide synthases in human brain tumours and peritumoral areas. J Neurol Sci 1998; 155: 196-203
25. Homayoun P, Lust WD, Harik SI. Effect of several vasoactive agents on guanylate cyclase activity in isolated rat brain microvessels. Neurosci Lett 1989; 107: 273-278
26. Marsault R, Frelin C. Activation by nitric oxide of guanylate cyclase in endothelial cells from brain capillaries. J Neurochem 1992; 59: 942-945
27. Luo D, Leung E, Vincent SR. Nitric oxide-dependent efflux of cGMP in rat cerebellar cortex: An in vivo microdialysis study. J Neurosci 1994; 14: 263-271
28. Rupin A, Behr-Roussel D, Verbeuren TJ. Long-lasting cyclic guanosine-3′,5′-monophosphate accumulation in the medium of cultured smooth muscle cells from atherosclerotic rabbit aortas in response to exogenous or endogenous nitric oxide. [In Process Citation]. Fundam Clin Pharmacol 2000; 14: 453-459
29. Poulopoulou C, Nowak LM. Extracellular 3′,5′ cyclic guanosine monophosphate inhibits kainate-activated responses in cultured mouse cerebellar neurons. J Pharmacol Exp Ther 1998; 286: 99-109
30. Fabian G, Szabo CA, Bozo B, Greenwood J, Adamson P, Deli MA, Joo F, Krizbai IA, Szucs M. Expression of G-protein subtypes in cultured cerebral endothelial cells. Neurochem Int 1998; 33: 179-185
31. Revest PA, Abbott NJ, Gillespie JI. Receptor-mediated changes in intracellular [Ca2+] in cultured rat brain capillary endothelial cells. Brain Res 1991; 549: 159-161
32. Bausback HH, Ward PE. Kallidin and bradykinin metabolism by isolated cerebral microvessels. Biochem Pharmacol 1988; 37: 2973-2978
33. Palmieri FE, Bausback HH, Churchill L, Ward PE. Kinin and enkephalin conversion by an endothelial, plasma membrane carboxypeptidase. Biochem Pharmacol 1986; 35: 2749-2756
34. Chen EY, Emerich DF, Bartus RT, Kordower JH. B2 bradykinin receptor immunoreactivity in rat brain. J Comp Neurol 2000; 427: 1-18